Company intelligence / Profile preview

CHROMagar Microbiology

Paris, Île-de-France, Francechromagar.com ↗

Ownership: Private
Employees: ~40
Development stage: Commercial

Overview

CHROMagar has commercialized over 50 chromogenic media products that enable rapid and reliable detection and differentiation of a wide range of clinically relevant microbes. Their technology allows for faster results compared to traditional methods—often within 18–24 hours—and supports infection control efforts globally[1][3][4].

Industry: Metabolite Diagnostics

Partnerships

Becton Dickinson (BD): Licensed production/distribution agreement for certain chromogenic media under the BBL™ brand with co-promotion using the CHROMagar logo[4].Global network of >250 distributors across more than 80 countries[1][3].

Beyond the preview

Go deeper on CHROMagar Microbiology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CHROMagar Microbiology.

Explore the full profile